首页> 外文期刊>European Journal of Cancer Supplements >TAMOXIFEN IN THE TREATMENT OF RECURRENT, ADVANCED BORDER LINE OVARIAN CANCER: A SINGLE CENTRE EXPERIENCE
【24h】

TAMOXIFEN IN THE TREATMENT OF RECURRENT, ADVANCED BORDER LINE OVARIAN CANCER: A SINGLE CENTRE EXPERIENCE

机译:他莫昔芬在复发性,先进性卵巢癌治疗中的作用:单中心经验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Treatment of borderline ovarian tumours is based on surgery while chemotherapy is poorly effective. Advance border line ovarian tumours are rare nad response to chemotherapy is poor. Border line cancer frequently express estrogen receptors and few cases responding to hormonal treatments have been reported.
机译:背景:卵巢交界性肿瘤的治疗以手术为基础,而化疗效果不佳。晚期交界性卵巢肿瘤很少见,对化疗的反应较差。边界线癌经常表达雌激素受体,并且已经报道了很少几种对激素治疗有反应的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号